Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2015 | 03-2015 | 01-2015 | 10-2014 | 07-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -2,939 | -9,095 | -6,226 | -2,171 |
| Depreciation Amortization | N/A | 226 | 532 | 314 | 48 |
| Accounts receivable | N/A | -13 | -1,012 | -818 | 205 |
| Other Working Capital | N/A | 230 | 5 | 1,019 | 284 |
| Other Operating Activity | 0 | -47 | 1,449 | 817 | -348 |
| Operating Cash Flow | $N/A | $-2,543 | $-8,121 | $-4,895 | $-1,982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -4 | N/A | N/A |
| Purchase Of Investment | N/A | -7,850 | -44,805 | -41,655 | -35,627 |
| Sale Of Investment | N/A | 9,535 | 4,284 | 2,469 | 1,065 |
| Purchase Sale Intangibles | N/A | -15 | -90 | -64 | -15 |
| Other Investing Activity | 0 | -15 | -91 | -64 | -15 |
| Investing Cash Flow | $N/A | $1,670 | $-40,615 | $-39,250 | $-34,577 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 172 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 544 | 544 | 544 |
| Other Financing Activity | 0 | -47 | -384 | -364 | -348 |
| Financing Cash Flow | $N/A | $-47 | $332 | $180 | $196 |
| Beginning Cash Position | N/A | 11,676 | 58,321 | 58,321 | 58,321 |
| End Cash Position | N/A | 10,757 | 9,916 | 14,356 | 21,958 |
| Net Cash Flow | $N/A | $-920 | $-48,405 | $-43,964 | $-36,363 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2,543 | -8,121 | -4,895 | -1,982 |
| Capital Expenditure | N/A | N/A | -4 | N/A | N/A |
| Free Cash Flow | 0 | -2,543 | -8,126 | -4,895 | -1,982 |